Table 2 Problems reported on the EQ-5D-3L dimensions by patients in the 9 National Quality Registers (NQRs) and in the general population
Patient group in NQRs/ general population | Severity level | EQ-5D-3L dimension | EQ VAS score Mean (SD) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Baseline | 1-year follow-up | |||||||||||||
Mobility | Self-care | Usual activities | Pain/ discomfort | Anxiety/ depression | Mobility | Self-care | Usual activities | Pain/ discomfort | Anxiety/ depression | Baseline | 1-year follow-up | |||
% | % | % | % | % | % | % | % | % | % | |||||
Intervention-based registers | Spine (n = 44,196) | Level 1 | 15.3 | 79.7 | 27.7 | 0.6 | 41.9 | 57.7 | 91.7 | 65.9 | 23.0 | 62.4 | 47.8 (22.1) | 67.9 (22.5) |
Level 2 | 82.7 | 19.1 | 53.4 | 49.5 | 52.1 | 42.1 | 7.8 | 29.8 | 63.2 | 33.4 | ||||
Level 3 | 2.0 | 1.2 | 19.0 | 49.9 | 6.0 | 0.3 | 0.5 | 4.4 | 13.8 | 4.2 | ||||
Hip (n = 90,658) | Level 1 | 8.1 | 77.7 | 40.1 | 1.5 | 59.7 | 61.7 | 92.4 | 78.0 | 45.5 | 78.4 | 56.3 (22.2) | 76.7 (20.0) | |
Level 2 | 91.6 | 21.3 | 50.1 | 57.9 | 37.1 | 38.1 | 7.0 | 20.0 | 50.1 | 20.1 | ||||
Level 3 | 0.3 | 1.0 | 9.8 | 40.5 | 3.3 | 0.1 | 0.6 | 2.0 | 4.4 | 1.5 | ||||
Knee (n = 16,324) | Level 1 | 11.6 | 93.4 | 53.4 | 1.8 | 65.4 | 62.8 | 95.1 | 77.8 | 36.1 | 78.6 | 64.6 (22.1) | 76.2 (19.4) | |
Level 2 | 88.1 | 5.8 | 41.3 | 63.3 | 32.2 | 37.1 | 4.4 | 20.6 | 58.7 | 19.7 | ||||
Level 3 | 0.3 | 0.9 | 5.3 | 35.0 | 2.4 | 0.2 | 0.6 | 1.7 | 5.2 | 1.7 | ||||
Ankle (n = 668) | Level 1 | 3.9 | 88.3 | 37.7 | 1.1 | 57.5 | 36.7 | 91.5 | 63.9 | 24.3 | 71.4 | 55.8 (21.4) | 70.2 (18.9) | |
Level 2 | 94.5 | 10.8 | 49.3 | 49.7 | 38.2 | 62.9 | 7.5 | 32.2 | 65.6 | 26.2 | ||||
Level 3 | 1.7 | 0.9 | 13.0 | 49.3 | 4.3 | 0.5 | 1.1 | 3.9 | 10.2 | 2.4 | ||||
Cruciate ligament (n = 8,155) | Level 1 | 67.0 | 97.4 | 53.6 | 15.2 | 49.6 | 86.9 | 98.9 | 79.0 | 35.0 | 65.2 | 62.8 (23.0) | 74.5 (19.9) | |
Level 2 | 32.7 | 2.1 | 37.4 | 79.0 | 44.9 | 13.1 | 0.8 | 19.4 | 61.9 | 31.5 | ||||
Level 3 | 0.3 | 0.5 | 9.0 | 5.7 | 5.5 | 0.1 | 0.3 | 1.6 | 3.1 | 3.3 | ||||
BOA (n = 6,690) | Level 1 | 42.9 | 96.0 | 75.6 | 2.4 | 67.0 | 53.3 | 96.2 | 80.1 | 9.8 | 71.1 | 68.3 (18.6) | 70.4 (18.7) | |
Level 2 | 57.0 | 3.7 | 23.0 | 87.3 | 31.7 | 46.6 | 3.4 | 19.2 | 82.6 | 27.9 | ||||
Level 3 | 0.1 | 0.4 | 1.4 | 10.3 | 1.2 | 0.1 | 0.4 | 0.8 | 7.6 | 1.1 | ||||
Diagnosis-based registers | Heart failure (n = 1,044) | Level 1 | 60.6 | 91.9 | 72.6 | 47.7 | 60.3 | 59.3 | 91.3 | 72.8 | 49.2 | 62.7 | 65.4 (18.9) | 67.4 (18.8) |
Level 2 | 39.2 | 7.7 | 24.0 | 47.5 | 36.6 | 40.2 | 8.0 | 24.2 | 43.5 | 34.4 | ||||
Level 3 | 0.2 | 0.5 | 3.5 | 4.8 | 3.2 | 0.5 | 0.8 | 3.0 | 7.3 | 2.9 | ||||
Respiratory failure (n = 725) | Level 1 | 22.8 | 62.3 | 25.9 | 29.0 | 42.1 | 17.0 | 53.4 | 19.5 | 23.9 | 37.5 | 51.1 (21.3) | 49.1 (20.4) | |
Level 2 | 75.6 | 32.4 | 53.8 | 57.7 | 49.0 | 79.0 | 38.5 | 50.5 | 60.0 | 52.3 | ||||
Level 3 | 1.7 | 5.2 | 20.3 | 13.4 | 9.0 | 4.0 | 8.1 | 30.1 | 16.1 | 10.2 | ||||
Bipolar (n = 3,610) | Level 1 | 85.7 | 94.9 | 70.3 | 53.0 | 38.4 | 82.5 | 93.7 | 69.5 | 50.6 | 39.6 | 66.3 (21.1) | 67.2 (20.1) | |
Level 2 | 14.1 | 4.7 | 26.0 | 40.3 | 50.6 | 17.0 | 5.8 | 26.5 | 41.6 | 49.8 | ||||
Level 3 | 0.2 | 0.4 | 3.7 | 6.8 | 11.0 | 0.5 | 0.4 | 4.1 | 7.8 | 10.5 | ||||
General population (n = 41,761) | Level 1 | 91.3 | 98.6 | 91.6 | 53.5 | 68.4 | - | - | - | - | - | 79.5 (18.3) | - | |
Level 2 | 8.6 | 1.1 | 7.3 | 42.7 | 29.0 | - | - | - | - | - | ||||
Level 3 | 0.1 | 0.4 | 1.1 | 3.8 | 2.7 | - | - | - | - | - | ||||